Literature DB >> 23932456

Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study).

Alain Vergnenègre1, Stéphane Hominal, Achille Edem Tchalla, Henri Bérard, Isabelle Monnet, Gislaine Fraboulet, Nathalie Baize, Clarisse Audigier-Valette, Gilles Robinet, Gérard Oliviero, Hervé Le Caer, Pascal Thomas, Laurence Gérinière, Bénédicte Mastroianni, Christos Chouaïd.   

Abstract

INTRODUCTION: Few studies assessed, in real life, symptoms, specific interventions and factors influencing palliative care (PC) initiation for patients with advanced non-small-cell lung cancer (NSCLC). The objective of this study was to examine, in a prospective cohort of advanced NSCLC patients, PC use and factors associated with early (≤3 months after diagnosis) PC initiation.
METHODS: It was an observational multicenter study. Each center included 10 consecutive patients with PC initiation.
RESULTS: 514 patients were enrolled by 39 centers (age: 62.3 ± 10.7 years, performance status: 0/1; 68.6% cases). At baseline, the most frequent symptoms concerned pain (43.6%), malnutrition (37%) and psychological disorders (25.3%). Specific interventions were infrequent for pain control and malnutrition, but were more numerous for psychological and social problems and terminal care. Median time between diagnosis and PC initiation was 35 [13-84] days, median PC duration was 4.2 [0.6-9.3] months. Median overall survival was 8.6 [6.6-10.7] months; median survival after PC initiation was 3.6 [3.2-4.5] months. In multivariate analysis, only PS ≥2 was linked to early PC.
CONCLUSION: This study showed that early PC initiation is not a standard for patients with advanced NSCLC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Economics; Non-small-cell lung cancer; Observational study; Palliative care; Quality of care

Mesh:

Year:  2013        PMID: 23932456     DOI: 10.1016/j.lungcan.2013.07.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

1.  Disparate survival trends in histologic subtypes of metastatic non-small cell lung cancer: a population-based analysis.

Authors:  Adam J Olszewski; Shihab Ali; Sabrina M Witherby
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 2.  [Progress in Palliative Care Benefit of Elderly Patients with Non-small Cell Lung Cancer].

Authors:  Shantong Jiang; Pingping Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-07

3.  Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study.

Authors:  Yan Lan; Shuo Zhou; Weihong Feng; Ying Qiao; Xueming Du; Fenge Li
Journal:  Clinics (Sao Paulo)       Date:  2021-03-24       Impact factor: 2.365

4.  A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy.

Authors:  Fenge Li; Liping Wang; Yixiang Zhang; Weihong Feng; Tao Ju; Zaiping Liu; Zhenglu Wang; Xueming Du
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.